HubXchange Boston 2022 – March 15

Roundtable Discussion

Natalie LaFranzo

Natalie LaFranzo, PhD
Personalis, Inc.

Tuesday, March 15 

Beyond MRD: Developing Patient-Centered Diagnostics through Tumor-Informed Comprehensive Insights

  • Earlier detection of disease recurrence
  • Utility in more disease indications, and at earlier stages of disease
  • Clinical trial needs for patient enrichment
  • Screening/enrollment
  • Surrogate endpoint analysis
  • Necessity for additional biomarker readouts

HubXchange Boston, March 15, 2022